Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?

Sekerak, R., Lerner, J. B.-A., Prasad, P., & Prasad, M. (2023). Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease? Cleveland Clinic Journal of Medicine, 90(10), 607–609. https://doi.org/10.3949/ccjm.90a.23004
Authors:
Richard Sekerak
Jordyn Lerner
Pooja Prasad
Megha Prasad
Affiliated Authors:
Richard Sekerak
Megha Prasad
Columbia Affiliation:
Subjects:
Sodium-Glucose Transporter 2 Inhibitors (MeSH)
Heart Failure (MeSH)
Renal Insufficiency, Chronic (MeSH)
Diabetes Mellitus, Type 2 (MeSH)
Management of Diabetes Mellitus and Cardiovascular Risk (OpenAlex Topic)
Management of Hyperkalemia in Kidney Diseases (OpenAlex Topic)
Diagnosis and Treatment of Heart Failure (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.3949/ccjm.90a.23004
PMID:
37783497
DOI:
10.3949/ccjm.90a.23004
Journal:
Cleveland Clinic Journal of Medicine
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record

Record Created: